Sotalol - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509245603

Publication Date:

September 20, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Sotalol is a medication used to treat abnormal heart rhythms. Sotalol is a non-selective competitive beta-adrenergic receptor blocker that also exhibits Class III antiarrhythmic properties.
The global market for Sotalol was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Sotalol was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sotalol was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Sotalol was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Sotalol include Bayer, GSK, Bristol-Myers Squibb(BMS), Arbor Pharmaceuticals, Cambrex, Arevipharma, Shaanxi Hanjiang Pharmaceutical Group, Samarth Pharma Pvt. Ltd. and Cipla Limited, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sotalol, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sotalol by region & country, by Type, and by Application.
The Sotalol market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sotalol.
麻豆原创 Segmentation
By Company
Bayer
GSK
Bristol-Myers Squibb(BMS)
Arbor Pharmaceuticals
Cambrex
Arevipharma
Shaanxi Hanjiang Pharmaceutical Group
Samarth Pharma Pvt. Ltd.
Cipla Limited
Segment by Type:
40mg Sotalol
80mg Sotalol
Segment by Application
Sustained Ventricular Tachycardia
Atrial Fibrillation/Flutter
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sotalol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sotalol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sotalol in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Sotalol Product Introduction
1.2 Global Sotalol 麻豆原创 Size Forecast
1.2.1 Global Sotalol Sales Value (2019-2030)
1.2.2 Global Sotalol Sales Volume (2019-2030)
1.2.3 Global Sotalol Sales Price (2019-2030)
1.3 Sotalol 麻豆原创 Trends & Drivers
1.3.1 Sotalol Industry Trends
1.3.2 Sotalol 麻豆原创 Drivers & Opportunity
1.3.3 Sotalol 麻豆原创 Challenges
1.3.4 Sotalol 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sotalol Players Revenue Ranking (2023)
2.2 Global Sotalol Revenue by Company (2019-2024)
2.3 Global Sotalol Players Sales Volume Ranking (2023)
2.4 Global Sotalol Sales Volume by Company Players (2019-2024)
2.5 Global Sotalol Average Price by Company (2019-2024)
2.6 Key Manufacturers Sotalol Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Sotalol Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Sotalol
2.9 Sotalol 麻豆原创 Competitive Analysis
2.9.1 Sotalol 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Sotalol Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sotalol as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 40mg Sotalol
3.1.2 80mg Sotalol
3.2 Global Sotalol Sales Value by Type
3.2.1 Global Sotalol Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Sotalol Sales Value, by Type (2019-2030)
3.2.3 Global Sotalol Sales Value, by Type (%) (2019-2030)
3.3 Global Sotalol Sales Volume by Type
3.3.1 Global Sotalol Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Sotalol Sales Volume, by Type (2019-2030)
3.3.3 Global Sotalol Sales Volume, by Type (%) (2019-2030)
3.4 Global Sotalol Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Sustained Ventricular Tachycardia
4.1.2 Atrial Fibrillation/Flutter
4.2 Global Sotalol Sales Value by Application
4.2.1 Global Sotalol Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sotalol Sales Value, by Application (2019-2030)
4.2.3 Global Sotalol Sales Value, by Application (%) (2019-2030)
4.3 Global Sotalol Sales Volume by Application
4.3.1 Global Sotalol Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Sotalol Sales Volume, by Application (2019-2030)
4.3.3 Global Sotalol Sales Volume, by Application (%) (2019-2030)
4.4 Global Sotalol Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Sotalol Sales Value by Region
5.1.1 Global Sotalol Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sotalol Sales Value by Region (2019-2024)
5.1.3 Global Sotalol Sales Value by Region (2025-2030)
5.1.4 Global Sotalol Sales Value by Region (%), (2019-2030)
5.2 Global Sotalol Sales Volume by Region
5.2.1 Global Sotalol Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Sotalol Sales Volume by Region (2019-2024)
5.2.3 Global Sotalol Sales Volume by Region (2025-2030)
5.2.4 Global Sotalol Sales Volume by Region (%), (2019-2030)
5.3 Global Sotalol Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Sotalol Sales Value, 2019-2030
5.4.2 North America Sotalol Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Sotalol Sales Value, 2019-2030
5.5.2 Europe Sotalol Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Sotalol Sales Value, 2019-2030
5.6.2 Asia Pacific Sotalol Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Sotalol Sales Value, 2019-2030
5.7.2 South America Sotalol Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Sotalol Sales Value, 2019-2030
5.8.2 Middle East & Africa Sotalol Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sotalol Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sotalol Sales Value
6.2.1 Key Countries/Regions Sotalol Sales Value, 2019-2030
6.2.2 Key Countries/Regions Sotalol Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Sotalol Sales Value, 2019-2030
6.3.2 United States Sotalol Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Sotalol Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sotalol Sales Value, 2019-2030
6.4.2 Europe Sotalol Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Sotalol Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sotalol Sales Value, 2019-2030
6.5.2 China Sotalol Sales Value by Type (%), 2023 VS 2030
6.5.3 China Sotalol Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sotalol Sales Value, 2019-2030
6.6.2 Japan Sotalol Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Sotalol Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sotalol Sales Value, 2019-2030
6.7.2 South Korea Sotalol Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Sotalol Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sotalol Sales Value, 2019-2030
6.8.2 Southeast Asia Sotalol Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Sotalol Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sotalol Sales Value, 2019-2030
6.9.2 India Sotalol Sales Value by Type (%), 2023 VS 2030
6.9.3 India Sotalol Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bayer
7.1.1 Bayer Company Information
7.1.2 Bayer Introduction and Business Overview
7.1.3 Bayer Sotalol Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Bayer Sotalol Product Offerings
7.1.5 Bayer Recent Development
7.2 GSK
7.2.1 GSK Company Information
7.2.2 GSK Introduction and Business Overview
7.2.3 GSK Sotalol Sales, Revenue and Gross Margin (2019-2024)
7.2.4 GSK Sotalol Product Offerings
7.2.5 GSK Recent Development
7.3 Bristol-Myers Squibb(BMS)
7.3.1 Bristol-Myers Squibb(BMS) Company Information
7.3.2 Bristol-Myers Squibb(BMS) Introduction and Business Overview
7.3.3 Bristol-Myers Squibb(BMS) Sotalol Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Bristol-Myers Squibb(BMS) Sotalol Product Offerings
7.3.5 Bristol-Myers Squibb(BMS) Recent Development
7.4 Arbor Pharmaceuticals
7.4.1 Arbor Pharmaceuticals Company Information
7.4.2 Arbor Pharmaceuticals Introduction and Business Overview
7.4.3 Arbor Pharmaceuticals Sotalol Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Arbor Pharmaceuticals Sotalol Product Offerings
7.4.5 Arbor Pharmaceuticals Recent Development
7.5 Cambrex
7.5.1 Cambrex Company Information
7.5.2 Cambrex Introduction and Business Overview
7.5.3 Cambrex Sotalol Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Cambrex Sotalol Product Offerings
7.5.5 Cambrex Recent Development
7.6 Arevipharma
7.6.1 Arevipharma Company Information
7.6.2 Arevipharma Introduction and Business Overview
7.6.3 Arevipharma Sotalol Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Arevipharma Sotalol Product Offerings
7.6.5 Arevipharma Recent Development
7.7 Shaanxi Hanjiang Pharmaceutical Group
7.7.1 Shaanxi Hanjiang Pharmaceutical Group Company Information
7.7.2 Shaanxi Hanjiang Pharmaceutical Group Introduction and Business Overview
7.7.3 Shaanxi Hanjiang Pharmaceutical Group Sotalol Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Shaanxi Hanjiang Pharmaceutical Group Sotalol Product Offerings
7.7.5 Shaanxi Hanjiang Pharmaceutical Group Recent Development
7.8 Samarth Pharma Pvt. Ltd.
7.8.1 Samarth Pharma Pvt. Ltd. Company Information
7.8.2 Samarth Pharma Pvt. Ltd. Introduction and Business Overview
7.8.3 Samarth Pharma Pvt. Ltd. Sotalol Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Samarth Pharma Pvt. Ltd. Sotalol Product Offerings
7.8.5 Samarth Pharma Pvt. Ltd. Recent Development
7.9 Cipla Limited
7.9.1 Cipla Limited Company Information
7.9.2 Cipla Limited Introduction and Business Overview
7.9.3 Cipla Limited Sotalol Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Cipla Limited Sotalol Product Offerings
7.9.5 Cipla Limited Recent Development
8 Industry Chain Analysis
8.1 Sotalol Industrial Chain
8.2 Sotalol Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sotalol Sales Model
8.5.2 Sales Channel
8.5.3 Sotalol Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Bayer
GSK
Bristol-Myers Squibb(BMS)
Arbor Pharmaceuticals
Cambrex
Arevipharma
Shaanxi Hanjiang Pharmaceutical Group
Samarth Pharma Pvt. Ltd.
Cipla Limited

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.